FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Levi Strauss lifts outlook, warns on future tariffs, showcasing resilience and adaptability in navigating trade challenges.
Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, further straining their relations over the Ukraine conflict.
FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Levi Strauss lifts outlook, warns on future tariffs, showcasing resilience and adaptability in navigating trade challenges.
Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, further straining their relations over the Ukraine conflict.